TITLE

Raltegravir

PUB. DATE
November 2009
SOURCE
Reactions Weekly;11/14/2009, Issue 1278, p25
SOURCE TYPE
Periodical
DOC. TYPE
Case Study
ABSTRACT
The article describes the cases of two men with HIV infection who developed insomnia when raltegravir was substituted into their stable antiretroviral therapy. In the first case, the insomnia resolved when all antiretroviral therapy was stopped. The second patient's insomnia resolved immediately after the drug was withdrawn.
ACCESSION #
45226686

 

Related Articles

  • Analyzing Sleep Abnormalities in HIV-Infected Patients Treated with Efavirenz. Gallego, Lucía; Barreiro, Pablo; del Río, Rafael; de Requena, Daniel González; Rodríguez-Albari&nteldi;o, Apolinar; Gonzá-Lahoz, Juan; Soriano, Vincent // Clinical Infectious Diseases;2/1/2004, Vol. 38 Issue 3, p430 

    Ambulatory electroencephalogram monitoring was performed for 18 HIV-infected subjects treated with efavirenz with and without insomnia and for 13 healthy control subjects. All patients receiving efavirenz had longer sleep latencies and shorter duration of deep sleep, although poor sleepers also...

  • CE/CME questions.  // AIDS Alert;Aug2007, Vol. 22 Issue 8, p95 

    A quiz about antiretrovirals is presented.

  • IAS encourages commitment to ART treatment as prevention.  // Infectious Disease News;Dec2009, Vol. 22 Issue 12, p18 

    The article reports that the International AIDS Society has praised the World Health Organization (WHO) for a new effort to boost antiretroviral therapy (ART) as HIV prevention and not just a treatment strategy, in December 2009.

  • pentafuside:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p175 

    An encyclopedia entry for "pentafuside," which refers to the generic name for an antiretroviral, is presented.

  • The International Pharmacopoeia.  // WHO Drug Information;2005, Vol. 19 Issue 2, p137 

    Provides specifications and monographs antiretroviral agents in collaboration of the International Pharmacopoeia with manufacturers, laboratories, governments and regulatory bodies.

  • Expanding ART eligibility could be cost effective.  // PharmacoEconomics & Outcomes News;7/6/2013, Issue 683, p5 

    The article focuses on a study which examined the health benefits and cost effectiveness of expanding antiretroviral therapy (ART).

  • Nevirapine increases lumefantrine concentrations.  // Reactions Weekly;10/22/2011, Issue 1374, p6 

    The article reports on a study which found that nevirapine-based antiretroviral therapy (ART) decreased the area under the curve (AUC) of artemether and dihydroartemisinin but unexpectedly increased lumefantrine concentrations.

  • Antiretrovirals.  // Reactions Weekly;May2015, Vol. 1553 Issue 1, p40 

    The article presents a case study of patients who developed various toxicities during treatment with antiretrovirals.

  • Simple, Effective Interventions Are Key to Improving Adherence in Marginalized Populations. Mills, Edward J.; Cooper, Curtis // Clinical Infectious Diseases;10/1/2007, Vol. 45 Issue 7, p916 

    The article presents the authors' view on the article "Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: A marginal structural model analysis," by M.L. Petersen and colleagues. The association between pillbox use and both improved...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics